Sign In

Lara Mott

CEO and Co-founder at ImproveWell, a fast-growing HealthTech SME #EngageToImprove Current Entrepreneur in Residence for BMJ.

Professional Background

Lara Mott is a distinguished professional with an extensive background in pharmacology, corporate affairs, and investor relations. Currently, she serves as the CEO and co-founder of ImproveWell LTD, a company dedicated to improving healthcare environments by empowering staff and fostering continuous improvement. Her role at ImproveWell reflects her commitment to harnessing innovative solutions for impactful change within the healthcare sector.

Before taking the helm at ImproveWell, Lara had an impressive tenure at BMJ, where she was recognized as the Entrepreneur in Residence. This role allowed her to merge her passion for healthcare and entrepreneurship, providing invaluable insights into the evolving landscape of medicine and technology. Lara's expertise extends beyond entrepreneurship; she has held numerous influential positions that underscore her strategic acumen in corporate communications and investor relations.

Lara’s previous experience includes serving as Vice President of Corporate Affairs at Circassia, where she was instrumental in the company's communication strategies, ensuring clear engagement with stakeholders and the public. Her role at Circassia showcased her ability to navigate the complex intersection of business and healthcare, melding operational insights with effective communication. In addition, she served as Deputy Chair of the Communications Advisory Committee at the BioIndustry Association, further establishing her role as a thought leader in industry communications.

Education and Achievements

Lara Mott's educational journey began at Kingston Grammar School, where she excelled academically, eventually becoming Vice-Captain, a role that highlighted her leadership capabilities from an early age. Following her successful school career, she pursued a first-class BSc Hons in Pharmacology from the prestigious University of Bristol. This solid foundation in pharmacological sciences has been pivotal in her ability to comprehend and engage with healthcare-related industries, positioning her advantageously for her subsequent career in pharmaceuticals and biotech.

In addition to her formal education, Lara has accumulated a wealth of experience in high-stakes environments. She has held the role of Director of Investor Relations at GHO Capital Partners LLP, where she was responsible for shaping the company's investor engagement strategies. Prior to this position, she made significant contributions as the Head of Investor Relations and Corporate Communications at Oxford BioMedica, a leading gene and cell therapy business, further solidifying her expertise in the biotech space.

Notable Achievements

Lara's professional journey is marked by numerous achievements that reflect her dedication and impact across various roles. As a board member at Selfless, she played a crucial role in guiding the organization's mission to promote social responsibility and corporate ethics. With her vast knowledge in financial communications, gained during her tenure as a Consultant at Financial Dynamics (now FTI Consulting), Lara has adeptly managed communication strategies that resonate with both investors and the public.

Her early career experiences include serving as an Investor Relations Manager at Apax Partners, where she honed her analytical skills and deepened her understanding of market dynamics. Lara's time as a Research Analyst at Höegh Capital Partners Advisors Ltd. provided her with foundational insights into investment strategy and market research, enriching her readiness for future high-impact roles.

Lara Mott continues to be a driving force in the intersection of healthcare and corporate communications. Her journey exemplifies a blend of academic excellence, significant leadership roles, and a steadfast commitment to advancing the fields of pharmacology and healthcare communications. With a unique perspective shaped by her diverse experiences, Lara stands out as a leader who is poised to influence the future of health tech and corporate affairs, making notable strides in how organizations interact with stakeholders and the broader communities they serve.

Related Questions

How did Lara Mott leverage her education in pharmacology during her tenure at Oxford BioMedica?
What inspired Lara Mott to co-found ImproveWell LTD, and what vision does she have for the company?
Can Lara Mott share her experiences and lessons learned from her time as Entrepreneur in Residence at BMJ?
What strategies did Lara Mott implement during her role as Vice President of Corporate Affairs at Circassia to effectively engage stakeholders?
How has Lara Mott's background as Vice-Captain at Kingston Grammar School influenced her leadership style in the corporate world?
Lara Mott
Add to my network

Location

London, England, United Kingdom